Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Account Payables (2016 - 2025)

Avanos Medical's Change in Account Payables history spans 11 years, with the latest figure at $300000.0 for Q4 2024.

  • For Q4 2024, Change in Account Payables fell 81.25% year-over-year to $300000.0; the TTM value through Dec 2024 reached -$900000.0, up 93.75%, while the annual FY2025 figure was $600000.0, 166.67% up from the prior year.
  • Change in Account Payables for Q4 2024 was $300000.0 at Avanos Medical, up from -$1.2 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $30.2 million in Q1 2022 and bottomed at -$14.2 million in Q3 2023.
  • The 5-year median for Change in Account Payables is $300000.0 (2024), against an average of -$563157.9.
  • The largest annual shift saw Change in Account Payables soared 587.1% in 2022 before it plummeted 2466.67% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at -$10.8 million in 2020, then increased by 10.19% to -$9.7 million in 2021, then soared by 113.4% to $1.3 million in 2022, then grew by 23.08% to $1.6 million in 2023, then crashed by 81.25% to $300000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Change in Account Payables are $300000.0 (Q4 2024), -$1.2 million (Q3 2024), and -$2.3 million (Q2 2024).